Implications of SMAD4 Genetic Status in Recurrent Pancreatic Adenocarcinoma

被引：0
|
作者：
AlMasri, S. S. [1 ]
Zenati, M. [1 ]
Singhi, A. D. [1 ]
Lee, K. K. [1 ]
Bahary, N. [1 ]
Bartlett, D. [1 ]
Zureikat, A. [1 ]
机构：
[1] Univ Pittsburgh, Med Ctr, Surg Oncol, Pittsburgh, PA USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2020年 / 27卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
71
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [41] Association of SMAD4 loss with response to neoadjuvant chemotherapy with the autophagy inhibitor hydroxychloroquine in patients with pancreatic adenocarcinoma
    Fei, Naomi
    Wen, Sijin
    Rao, Pavan
    Ramanathan, Rajesh
    Hogg, Melissa E.
    Zureikat, Amer H.
    Lotze, Michael T.
    Bahary, Nathan
    Singhi, Aatur D.
    Zeh, Herbert
    Boone, Brian A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
  • [42] Large-scale analysis for treatment strategy according to genetic alterations of KRAS and DPC4 (SMAD4) genes in pancreatic ductal adenocarcinoma.
    Shin, Sang Hyun
    Kim, Song Cheol
    Song, Ki Byung
    Lee, Jae Hoon
    Hwang, Dae Wook
    Lee, Dong Joo
    Lee, Jung Woo
    Kim, Hyoung Eun
    Jun, Eunsung
    Park, Kwang-Min
    Lee, Young-Joo
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [43] Transcriptional activity of Smad4: Rule of the Smad4 activation domain
    de Caestecker, M
    Wang, D
    Parks, T
    Shioda, T
    Roberts, A
    Lechleider, R
    BONE, 1999, 24 (04) : 421 - 421
  • [44] Islet hypertrophy following pancreatic disruption of Smad4 signaling
    Simeone, Diane M.
    Zhang, Lizhi
    Treutelaar, Mary K.
    Zhang, Lanjing
    Graziano, Kathleen
    Logsdon, Craig D.
    Burant, Charles F.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2006, 291 (06): : E1305 - E1316
  • [45] Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy
    Kamata, Ken
    Takenaka, Mamoru
    Nishida, Naoshi
    Hara, Akane
    Otsuka, Yasuo
    Tanaka, Hidekazu
    Omoto, Shunsuke
    Minaga, Kosuke
    Yamao, Kentaro
    Chiba, Yasutaka
    Sakai, Kazuko
    Nishio, Kazuto
    Watanabe, Tomohiro
    Kudo, Masatoshi
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (11) : 1511 - 1519
  • [46] Impact of Smad4 and p53 mutations on the prognosis of patients with pancreatic ductal adenocarcinoma undergoing chemotherapy
    Ken Kamata
    Mamoru Takenaka
    Naoshi Nishida
    Akane Hara
    Yasuo Otsuka
    Hidekazu Tanaka
    Shunsuke Omoto
    Kosuke Minaga
    Kentaro Yamao
    Yasutaka Chiba
    Kazuko Sakai
    Kazuto Nishio
    Tomohiro Watanabe
    Masatoshi Kudo
    International Journal of Clinical Oncology, 2023, 28 : 1511 - 1519
  • [47] A study of Smad4, Smad6 and Smad7 in surgically resected samples of pancreatic ductal adenocarcinoma and their correlation with clinicopathological parameters and patient survival
    Singh P.
    Srinivasan R.
    Wig J.
    Radotra B.
    BMC Research Notes, 4 (1)
  • [48] Loss of SMAD4 Expression Is a Poor Prognostic Factor in Ampullary Adenocarcinoma
    Alkhasawneh, A.
    Duckworth, L. Vila
    Desai, N.
    Lu, X.
    Sommerfeld, A.
    George, T.
    Toro, T. Zuluaga
    LABORATORY INVESTIGATION, 2013, 93 : 143A - 143A
  • [49] Inactivation of Smad4/DPC4 is responsible for the loss of the tumor suppressant 4E-BP1 in pancreatic adenocarcinoma
    Azar, R.
    Susini, C.
    Pyronnet, S.
    Aftimos, G.
    Tawil, A.
    Geahchan, A.
    BULLETIN DU CANCER, 2007, 94 : S285 - S286
  • [50] SMAD4 Gene Methylation May Be Effective in Adenocarcinoma Lung Cancers
    Budak, Metin
    JOURNAL OF ACADEMIC RESEARCH IN MEDICINE-JAREM, 2021, 11 (01): : 86 - 89
12345